M.I.TECH Co.Ltd (179290) - Total Liabilities

Latest as of September 2025: ₩13.75 Billion KRW ≈ $9.32 Million USD

Based on the latest financial reports, M.I.TECH Co.Ltd (179290) has total liabilities worth ₩13.75 Billion KRW (≈ $9.32 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore M.I.TECH Co.Ltd net asset momentum to track the company's year-over-year net asset growth rate.

M.I.TECH Co.Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how M.I.TECH Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 179290 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

M.I.TECH Co.Ltd Competitors by Total Liabilities

The table below lists competitors of M.I.TECH Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
PT Janu Putra Sejahtera Tbk
JK:AYAM
Indonesia Rp287.21 Billion
SHANGHAI FUDAN H YC-,10
F:FDY
Germany €273.93 Million
Carnaby Resources Ltd
AU:CNB
Australia AU$10.04 Million
I-Berhad
KLSE:4251
Malaysia RM614.71 Million
Arcticzymes Technologies ASA
OL:AZT
Norway Nkr22.94 Million
UNICOMMERCE ESOLUTIONS LIMITED
NSE:UNIECOM
India Rs775.82 Million
Hillevax Inc
NASDAQ:HLVX
USA $27.09 Million
Cj Corp Pref 
KO:001045
Korea ₩29.95 Trillion

Liability Composition Analysis (2015–2024)

This chart breaks down M.I.TECH Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of M.I.TECH Co.Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.11 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how M.I.TECH Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for M.I.TECH Co.Ltd (2015–2024)

The table below shows the annual total liabilities of M.I.TECH Co.Ltd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩9.70 Billion
≈ $6.57 Million
+64.24%
2023-12-31 ₩5.90 Billion
≈ $4.00 Million
-43.78%
2022-12-31 ₩10.50 Billion
≈ $7.12 Million
-23.71%
2021-12-31 ₩13.76 Billion
≈ $9.33 Million
+8.55%
2020-12-31 ₩12.68 Billion
≈ $8.59 Million
+39.93%
2019-12-31 ₩9.06 Billion
≈ $6.14 Million
+101.71%
2018-12-31 ₩4.49 Billion
≈ $3.04 Million
-59.12%
2017-12-31 ₩10.99 Billion
≈ $7.45 Million
+191.39%
2016-12-31 ₩3.77 Billion
≈ $2.56 Million
+50.88%
2015-12-31 ₩2.50 Billion
≈ $1.69 Million
--

About M.I.TECH Co.Ltd

KQ:179290 Korea Medical Instruments & Supplies
Market Cap
$104.84 Million
₩154.71 Billion KRW
Market Cap Rank
#18963 Global
#874 in Korea
Share Price
₩4780.00
Change (1 day)
+0.84%
52-Week Range
₩4195.00 - ₩8170.00
All Time High
₩15478.41
About

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more